SANDOZ GEFITINIB

Sandoz Canada, Inc.🇨🇦 Health Canada

Approval Id: cd5a8eff99d7927c
Drug Approval Canada Name: SANDOZ GEFITINIB
Product Name: SANDOZ GEFITINIB
Status: Marketed
Status Date: 2019-06-26
Original Market Date: 2019-06-26
Din: 02487748
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01EB01 GEFITINIB
Atc Name: l 01 eb 01
Aig Number: 0149783001
Company Name: Sandoz Canada, Inc.
Company Address: 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path: /organization/sandoz-canada-inc

GEFITINIB

250 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

cd5a8eff99d7927c

Type

Standard